variance (and 17% of the genetic variance) in cannabis dependence symptoms may be attributable in part to the inclusion of conduct disorder in the models. In short, our study adds to a limited literature that has thus far produced mixed results regarding the degree of genetic overlap in AD and cannabis dependence symptomatology, with findings that match the highest estimates of common genetic influences to date (i.e., Xian et al., 2008).
